Home › Compare › EVOK vs YUM

EVOK vs YUM: Dividend Comparison 2026

EVOK yields 18.18% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $42.7K in total portfolio value· pulled ahead in Year 9
10 years
EVOK
EVOK
● Live price
18.18%
Share price
$11.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$65.3K
Annual income
$5,522.63
Full EVOK calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — EVOK vs YUM

📍 YUM pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEVOKYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EVOK + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EVOK pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVOK
Annual income on $10K today (after 15% tax)
$1,545.45/yr
After 10yr DRIP, annual income (after tax)
$4,694.24/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, YUM beats the other by $29,682.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVOK + YUM for your $10,000?

EVOK: 50%YUM: 50%
100% YUM50/50100% EVOK
Portfolio after 10yr
$86.6K
Annual income
$22,983.08/yr
Blended yield
26.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

EVOK
Analyst Ratings
9
Buy
3
Hold
Consensus: Buy
Price Target
$18.00
+63.6% upside vs current
Range: $18.00 — $18.00
Altman Z
-10.8
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVOK buys
0
YUM buys
0
No recent congressional trades found for EVOK or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEVOKYUM
Forward yield18.18% ✓1.86%
Annual dividend / share$2.00$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4% ✓
Portfolio after 10y$65.3K$107.9K ✓
Annual income after 10y$5,522.63$40,443.52 ✓
Total dividends collected$35.3K$81.2K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$18.00$173.15 ✓

Year-by-year: EVOK vs YUM ($10,000, DRIP)

YearEVOK PortfolioEVOK Income/yrYUM PortfolioYUM Income/yrGap
1$12,518$1,818.18$10,982$282.06+$1.5K → EVOK
2$15,522$2,127.13$12,189$438.29+$3.3K → EVOK
3$19,073$2,464.94$13,731$688.32+$5.3K → EVOK
4$23,239$2,830.78$15,789$1,097.12+$7.5K → EVOK
5$28,089$3,223.43$18,679$1,785.08+$9.4K → EVOK
6$33,697$3,641.30$22,975$2,988.18+$10.7K → EVOK
7$40,138$4,082.45$29,784$5,200.49+$10.4K → EVOK
8$47,492$4,544.69$41,408$9,539.16+$6.1K → EVOK
9← crossover$55,842$5,025.61$63,071$18,765.27$7.2K → YUM
10$65,274$5,522.63$107,930$40,443.52$42.7K → YUM

EVOK vs YUM: Complete Analysis 2026

EVOK — Stock

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Full EVOK Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this EVOK vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVOK vs SCHDEVOK vs JEPIEVOK vs OEVOK vs KOEVOK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.